Exsure Secures Rs 3 Crore Seed Funding to Develop Less Toxic Chemotherapy Delivery System

biotechnology

27 July 2026 at 7:21 pm

Exsure Secures Rs 3 Crore Seed Funding to Develop Less Toxic Chemotherapy Delivery System

HyperFast News

Summary

Bhubaneswar-based biotech company Exsure is developing a novel drug delivery system using exosomes to make chemotherapy less toxic and target cancer stem cells. The company, founded in 2021, recently raised Rs 3 crore in a seed round led by Unicorn India Ventures to advance its preclinical studies and expand sales of its research products.

Select what you want to create

Turn this story into an image post, carousel, video, audio reel, blog, and more — all from HyperFast News.

FAQ

Newsroom FAQs

About the public HyperFast News news feed powered by NewsEngine.